Search results for “site:dx.doi.org”

Page 3 of about 164 results

dx.doi.org 10.1136/bmj.n359

Covid-19: The E484K mutation and the risks it poses | The BMJ

The mutation E484K, first identified in the South African SARS-CoV-2 variant, has now been identified in the UK fast-spreading variant, prompting fears the virus is evolving further and could become resistant to vaccines. Jacqui Wise looks...

dx.doi.org 10.17487/RFC0812

Information on RFC 0812 » RFC Editor

Discuss this RFC: Send questions or comments to the mailing list iesg@ietf.org Abstract This RFC gives a description of what the NICNAME/WHOIS Server is and how to access it. This server together with the corresponding Identification Data Base provides online directory look-up equivalent to the...

Save: Information on RFC 0812 » RFC Editor
dx.doi.org 10.1136/bmj.m1086

Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists | The BMJ

Scientists and senior doctors have backed claims by France’s health minister that people showing symptoms of covid-19 should use paracetamol (acetaminophen) rather than ibuprofen, a drug they said might exacerbate the condition. The...

dx.doi.org 10.1136/bmj.n3144

Covid-19: Early studies give hope omicron is milder than other variants | The BMJ

Optimism is growing that the increasingly dominant omicron variant of SARS-CoV-2 may produce less severe disease than previous strains, after the findings of three early studies into the outcome of infection with the variant. Researchers...

dx.doi.org 10.1172/jci154886

JCI - The intersection of COVID-19 and autoimmunity

Review Free access | 10.1172/JCI154886 The intersection of COVID-19 and autoimmunity Jason S. Knight,1 Roberto Caricchio,2 Jean-Laurent Casanova,3,4,5,6 Alexis J. Combes,7 Betty Diamond,8 Sharon E. Fox,9,10 David A. Hanauer,11 Judith A. James,12 Yogendra Kanthi,13 Virginia Ladd,14 Puja Mehta,15...

dx.doi.org 10.3855/jidc.15126

Ruxolitinib as a treatment strategy for SARS-CoV-2 pneumonia: clinical experience in a real-world setting | The Journal of Infection in Developing Countries

Ruxolitinib as a treatment strategy for SARS-CoV-2 pneumonia: clinical experience in a real-world setting Authors Roberto Ovilla-Martinez Hematology, Hospital Angeles Lomas, Huixquilucan, Mexico Xochitl Cota-Rangel Jose De La Peña-Celaya Mariana Alejandra Alvarado-Zepeda Internal Medicine, Centro...

dx.doi.org 10.7759/cureus.7561

Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease | Cureus

An emerging viral infection is a global public health challenge. The development of modern, fast, and extensive transportation makes the outbreak hard to contain. Everyone is at risk, and the outbreak can rapidly turn into a pandemic...

dx.doi.org 10.7759/cureus.7782

Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction | Cureus

Patients with Covid-19 disease commonly present with symptoms related to respiratory illness, and less commonly they develop cardiovascular complications either on presentation or during the course of the disease. The mortality/morbidity...

Try “site:dx.doi.org” on: Marginalia · Mojeek · Wiby · DuckDuckGo · Bing · Google · Wikipedia · Internet Archive